A new study published this month in the Equine Veterinary Journal (EVJ)1 has concluded that toxins from the seeds of the sycamore tree (Acer pseudoplatanus) are the likely cause of Atypical Myopathy (AM) in Europe.
However, to avoid confusion, the authors of the study point out that the American Sycamore (also just called 'the sycamore' in the USA), is a completely different species: Platanus occidentalis. Furthermore, the sycamore found in the UK is also known as the sycamore maple in other countries.
The new research follows on the heels of a study in the USA earlier this year that linked toxins from the box elder tree (Acer negundo) with Seasonal Pasture Myopathy (SPM), the US equivalent of AM2. The discovery marks an important step for the future prevention of this fatal disease.
Atypical Myopathy is a highly fatal muscle disease in the UK and Northern Europe. In ten years, approximately twenty European countries have reported the disease. Incidences tend to occur repeatedly in the autumn and in the spring following large autumnal outbreaks. Horses that develop AM are usually kept in sparse pastures with an accumulation of dead leaves, dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed. SPM is a very similar disorder, prevalent in Midwestern USA and Eastern Canada that is now known to be caused by the ingestion of hypoglycin A, contained in seeds from the box elder tree.
The new European research1 was conducted by an international team led by Dominic Votion, University of Liege and involved 17 horses from Belgium, Germany and The Netherlands, suffering from Atypical Myopathy. High concentrations of a toxic metabolite of hypoglycin A, were identified in the serum of all of the horses. The pastures of 12 of the horses were visited by experienced botanists and the Acer pseudoplatanus, the sycamore maple, was found to be present in every case. This was the only tree common to all visited pastures.
Researchers believe hypoglycin A is the likely cause of both AM in Europe and SPM in North America. The sycamore and the box elder are known to produce seeds containing hypoglycin A and the pastures of the afflicted horses in Europe and the USA were surrounded by these trees.
Hypoglycin-A is found in various levels in the seeds of plants in the genus Acer as well as in various other genera in the family Sapindaceae such as ackee (Blighia sapida). In ackee, hypoglycin-A levels do vary with ripeness of the fruit and, if the fruit is eaten before it is mature, it causes hypoglycaemia to different degrees including a condition called "Jamaican vomiting sickness" (because of ackee's use in Jamaican cooking) and occasionally death in humans.
Researchers at the Universities of Minnesota2 and Liege are continuing their work to try to uncover exactly how the equine disease occurs. Dr Adrian Hegeman of University of Minnesota said: "It is likely that the most important contributing factors to horses becoming poisoned by hypoglycin-A are the availability of seed in the field combined with lack of other feeding options. The seeds from two species of maples (box elder and sycamore maples) that we have tested include significant quantities of hypoglycin-A.
"We know that seeds contain highly variable quantities from seed to seed, even within a single tree. We do not know yet how hypoglycin-A levels vary seasonally, nor do we know how its abundance varies with different levels of stress to the plant, though this may well explain seasonal variability in the occurrence of the malady. It is possible that conditions that stress the plants may contribute to significant seasonal changes in hypoglycin-A levels. At this point we just don't know. It is common held knowledge that trees under stress usually produce more seed."
Dr Jeff Gillman of University of Minnesota said: "Without question, further analysis of the seeds and other tissues from Acer species needs to be performed along with sampling of plant materials over multiple seasons and at various stress levels. Additionally, one cannot rule out more complex explanations for the seasonality of disease occurrence such as: animals may begin feeding on seed materials in response to depletion of more palatable choices under drought conditions; or simple explanations such as high wind events driving seeds into fields. These sorts of explanations for the occurrence of the disease do not depend on botanical variations in toxicity across seasons, sites or stress levels, yet also require consideration.
"Although limited examples are available, the experience of animals at a pasture site might also confer some degree of behavioral resistance to poisoning due to exposure at sub-lethal levels with prior exposure to seeds in the pasture."
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is an important advancement in our understanding of what causes AM and how it can be prevented. In immediate practical terms owners can take prompt measures to avoid exposing their horses to sycamore seeds this autumn. Where horses are grazing in the vicinity of sycamore trees, it is imperative that they are provided with sufficient supplementary feed as this will minimise the risk that horses might be tempted to ingest seeds containing this toxin. This must be done carefully and leaving wet hay on the ground should be avoided so providing extra carbohydrate feeds may be more practical."
References
Norbrook Laboratories has announced that Pestigon for Cats, the company's fipronil spot on solution against fleas and ticks, has been granted an extension to its licence which means it is now indicated against the Ixodes ricinus tick.
Previously, the cat product was only indicated for Dermacentor reticulatus.
The Pestigon dog spot on offers efficacy against the Dermacentor reticulatus, Rhipicephalus sanguineus and the Ixodes ricinus tick.
Michelle Jones, Norbrook's Small Animal Brand Manager said: "The extension of our licence for Pestigon in Cats is welcome news. The Ixodes ricinus tick is one of the most common ticks found in the UK. Pet owners need to be aware that choosing a treatment that kills ticks as well as fleas is vital, with ticks potentially spreading diseases such as lyme disease. We are therefore delighted that our Pestigon range now gives cat owners even more protection against fleas and ticks."
Michelle added: "Pestigon is only available through veterinary practices which means that pet owners have to visit their practice to purchase this flea and tick treatment. They can therefore receive expert advice at the point of purchase and discuss any concerns they may have."
Pestigon spot on is available from all wholesalers in packs of 3, 6 and 24. Norbrook also makes a household spray, Permaguard, and a range of customer support materials available from Norbrook Territory Managers.
Image: Ixodes ricinus Richard Bartz
Feline charity International Cat Care (the charity formerly known as FAB) has teamed up with Digital Photographer and Your Cat magazine to launch a photography competition, 'Picture Purrfect Cats', which they are asking veterinary surgeons and nurses to help spread the word about.
The charity, which undertakes feline welfare projects across the globe, is looking for exceptional images of cats, celebrating their unique appeal under the following categories:
The winner will be chosen by a panel of judges including International Cat Care CEO Claire Bessant, Digital Photographer editor, April Madden, and Your Cat magazine editor Sue Parslow.
The first prize is a weekend safari break for two at Port Lympne Wild Animal Park, Kent, which includes tented accommodation overlooking a watering hole where a variety of African animals, such as zebras, giraffes and rhinos drink - offering plenty of magical photo opportunities. The winner also will be invited to attend International Cat Care's annual event at Altitude 360 in London, where their photograph will be exhibited and they will be presented with their prize.
International Cat Care CEO, Claire Bessant, said: "They say a picture conveys a 1,000 words, so we are hoping for some high quality images which shout to the world about the beauty of cats, and therefore why it's important to ensure they are looked after properly. Our welfare projects are international, working with both owned and unowned cats, pedigrees and moggies. We've reflected this in our categories and are hoping for some very varied entries. Please visit our Facebook page and enter or have a look at our growing gallery of feline photographs and vote for your favourite."
Runners up from each category will receive a framed A3 print of their winning photograph, along with official merchandise from the charity. Young photographers, ages 12 - 17 years, can win a Samsung Galaxy Smart WiFi Compact Digital Camera.
You can help support the competition by tweeting or e-mailing this link to your clients: www.facebook.com/internationalcatcare. Alternatively, add it to your practice website or your newsletter. It'll be fun if one of your clients wins.
The deadline for the competition is 16th August 2013.
Vétoquinol - maker of Epiphen, the anti-epileptic phenobarbital for the control of epilepsy in dogs - has added a new client brochure and a fridge magnet to its Epiphen support packs, designed to help owners understand the condition and make it easier for them to comply with daily dosage requirements.
The new brochure is called What I need to know and is written for clients that have been prescribed Epiphen for their pet for the first time.
Abbie King, Product Manager for Epiphen, said: ''The inspiration for the new brochure came after spending time at the Animal Health Trust in Newmarket and realising how much information an owner needs to take in when their dog is diagnosed with epilepsy."
The new brochure covers the important information owners need to help them understand and manage their dog's epilepsy, including how Epiphen works, what they can do to help their dog, how to monitor seizures, where to find further information and frequently asked questions.
The Epiphen Treatment fridge magnet is designed as a quick reference guide to prescribing information that is needed every day when living with a dog with epilepsy. The magnet leaves space for the owner to write in their dog's name, dosage details and timings and their vet's phone number. Vétoquinol says it is especially helpful as a reference if more than one person is caring for the dog.
The new items enhance the existing Epiphen support pack, which comprises an owner manual, medication record and seizure diary, dog tags, seizure report pads, free serum level monitoring vouchers and a free, online resource at www.epiphenonline.co.uk
Vétoquinol also invites practitioners who are dealing with challenging cases to take advantage of its free Ask the expert scheme on 0800 169 8197 or email a case history to epiphen@vetoquinol.co.uk.
To order the new Epiphen support materials, ring 0800 1698197. Alternatively, visit: www.vetoquinol.co.uk to find out more.
Guidance for veterinary surgeons and veterinary nurses on client confidentiality and microchipping has been amended by the RCVS.
The amendments deal with situations when a client presents an animal registered in another person's name, and a new flow diagram has been added to provide additional practical advice for vets and VNs dealing with these types of situations.
Animals can be registered in a different name to that of the client for various reasons. For example, an animal may have been re-homed or sold, but the details on its microchip have not been updated; it could have been stolen; or, the owners may be involved in a civil dispute.
Veterinary surgeons in practice may be unsure what to do in these situations. The new guidance informs veterinary surgeons about their options and provides advice on client confidentiality and data protection issues.
The College advises that veterinary nurses employed by a veterinary surgeon or practice should discuss the issues with a senior veterinary surgeon in the practice before breaching client confidentiality.
The amendments apply to Chapter 14 of the supporting guidance to the RCVS Code of Professional Conduct. The supporting guidance and flow diagram are available at: www.rcvs.org.uk/confidentiality.
The British Equine Veterinary Association (BEVA) has released the results of a survey carried out earlier this year which has found that there may be up to 5 times as many veterinary graduates wanting to work in equine practice as there are jobs available.
The survey was carried out amongst the 2,500 vets and vet students who are members of BEVA to help ascertain manpower requirements of equine practices in the UK.
Of the 819 new veterinary graduates in the UK in 2012, BEVA says it estimates conservatively that between 10-15% intend to work in equine practice. Meanwhile, the extrapolated results of the survey suggest that in 2012 there was less than 1% growth in full time equine vet positions and as few as 24 new permanent jobs available in the UK.
BEVA says that in line with the survey's suggestion of restricted opportunities, some of its members are also finding that internships, commonly the domain of new graduates to gain paid, supervised experience in practice, are now often taken by vets with some post-graduate experience. Furthermore, unpaid externships, which traditionally gave vet students valuable work experience, appear to be being filled by unemployed veterinary graduates wanting to gain experience in order to improve their chances of securing a job in equine practice.
Tim Mair, a partner at Bell Equine Veterinary Clinic in Kent said: "Earlier this year we had more than 80 applications for just one internship. Several years ago we would expect 50 or so applications for an advertised intern post but now, without advertising at all, we are constantly receiving applications, not just from new graduates but also from those who have been qualified for a year or more."
Charlie Schreiber, a partner at Donnington Grove Veterinary Surgery in Berkshire, said: "We take on an average of two externs a month and over the past four years have had more than 350 applicants but their calibre is noticeably changing. We used to hear primarily from students but now it tends to be recent graduates or those who have already done a job in mixed practice and are keen to move into equine but can't find an internship."
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, said: "In addition to the numerous applications we received for our recently advertised internship position, we are inundated with unsolicited enquiries about job opportunities from recent veterinary graduates from across the globe. Our most recent advertisement for an equine veterinary nurse has attracted interest from a handful of recently qualified vets desperate to find work. This employment problem is not confined to internships; some of our recent interns have found it very difficult, if not impossible to find a job in horse practice, once they've completed their internship."
Amanda Piggot, a recent graduate, has first hand experience of the challenge of finding a suitable placement. She said: "I have always wanted to work in equine practice and my approach has been very strategic. It took me five months to find my current position at Kessock Equine Vets in Inverness, which necessitated moving 500 miles further north than I ideally wanted. For my next position I applied to Liphook twice and had no luck but I have now been accepted by Rossdales for a two year internship."
According to the British Veterinary Association (BVA) the problem isn't confined to equine practice. The Association's President Peter Jones said: "The findings of the BEVA survey make sober reading and reflect the growing concerns in the wider veterinary profession about opportunities for new graduates in all types of veterinary practice.
"The issue has recently been brought into sharp focus by the announcement of a new veterinary school opening at the University of Surrey in 2014, with many BVA and BEVA members worried about an oversupply of veterinary graduates into an already competitive market. We are expecting the results of the RCVS survey of recent graduates shortly and, alongside the findings of the BEVA survey, they will provide an evidence-base to build on as we continue to assess the UK veterinary manpower implications of potential new veterinary schools in the future."
BEVA is keen to help both potential employees and employers tackle the situation as constructively as possible. BEVA President Keith Chandler said: "BEVA is proud that equine practice is attractive to so many younger members of the profession and it can provide a rewarding and fulfilling career. However we urge all stakeholders to ensure that current and prospective veterinary students are fully aware of the very limited opportunities in equine practice. Most of all we urge the students themselves to consider carefully their career path and prospects before making their final decisions."
Next month the RCVS will be releasing details of a survey of vets who have graduated within the past five years and how easy they have found it to find a job that meets their needs.
The RCVS Disciplinary Committee has directed that Somerset-based veterinary surgeon Dr Marcus Hutber be removed from the Register, having found him guilty of serious professional misconduct following multiple complaints made against him.
During the 11-day hearing, the Disciplinary Committee heard eight, separate and unrelated complaints against Dr Marcus Hutber, made whilst he was the owner of the veterinary company Epivet Ltd, with practices in Williton and Wiveliscombe, in 2009. The complaints involved a series of allegations including lack of adequate professional care, failure to have regard to animal welfare, failure to make or maintain adequate clinical records (and to provide them on request), and failure to treat clients with courtesy and respect.
In the first case, Dr Hutber was found to have performed surgery on a dog inadequately; failed to provide adequate post-operative pain relief; failed to obtain informed consent for the surgery from the dog's owner; and, failed to keep adequate clinical records of the dog's treatment. In a second case of inadequate professional care, Dr Hutber failed to ensure a cat's condition was monitored adequately; failed to ensure that the cat received appropriate fluid therapy; and, failed to keep adequate clinical records.
Dr Hutber was found to have brought the profession into disrepute by speaking rudely to one of his clients. On a separate occasion, a different client was found to have been treated without due courtesy or respect when Dr Hutber told her to come to the practice at once to get tablets and give them to her dog, otherwise the dog would die (of a disease he had diagnosed without carrying out the necessary investigations) - an instruction he then later repeated despite being told the dog was now being treated at a different practice.
One other complaint, where charges were proved, involved Dr Hutber's refusal to provide an animal's clinical records to a former client.
The Disciplinary Committee found Dr Hutber's conduct in respect of the charges proved in relation to each complaint, standing alone and taken collectively, amounted to serious professional misconduct.
In reaching its findings, the Committee considered the oral evidence and written statements of 20 witnesses (including Dr Hutber), two expert witness reports, a large quantity of documentary evidence, Dr Hutber's extensive rebuttal material and Counsels' submissions. Generally, the Committee preferred the evidence of the College's witnesses to that of Dr Hutber. Despite the Committee accepting he was of previous good character, it found him to be unhelpful and uncooperative, frequently lapsing into periods of silence that could last minutes, and staring fixedly (and, in the Committee's view, intimidatingly) at witnesses and College Counsel. There were also inconsistencies between his written rebuttal to the College, his witness statement and his oral evidence, about which the Committee found him evasive and illogical.
The Committee considered Dr Hutber had shown no insight into the allegations, or appreciated the significance or impact of his conduct upon his clients and their animals. He had shown no remorse or regret for his actions, and had continued to assert that he had done nothing wrong.
Further, he had caused actual injury to an animal by subjecting it to unnecessary revision surgery; displayed an inadequate and incomplete understanding of the concept of informed consent; demonstrated a lamentable lack of concern for animal welfare; brought the profession into disrepute with his treatment of his clients; and, exhibited conduct that fell far short of that to be expected of a member of the veterinary profession.
Chairing and speaking on behalf of the Committee, Professor Peter Lees, said: "The Committee has found that there were fundamental failings in the Respondent's clinical competence, and that there were serious defects in his interpersonal skills in relation to clients. He has throughout displayed a tendency to blame others for things which have gone wrong. [The Committee] is not satisfied that there is a realistic prospect of the Respondent having the ability or inclination to remedy his failings [and] remains unconvinced that there is a real possibility of a change in his attitude.
"The Committee is fully conscious that the purpose of sanction is not to punish, but to protect animals and the wider public interest and to uphold the reputation of the veterinary profession. Having regard to the serious aggravating factors [in this case], the Committee considers that the Respondent's conduct, taken as a whole, is so serious that removal of his professional status is the only appropriate sanction."
Accordingly, the Committee directed the Registrar to remove Dr Hutber's name from the Register.
The full details of the Committee's findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
The RCVS has released the results of a survey which has found that increasing numbers of graduates over the last five years have had little impact on veterinary job prospects.
The survey was carried out for the RCVS by the Institute for Employment Studies, which asked the last five years' UK graduates who have registered with the College how long it took them to find work, how long they stayed in their first jobs, and why they moved on.
The online survey, which achieved a 43% response rate (1,354 responders), found that an average of 94% of graduates seeking a role in clinical practice obtained work within six months of starting to look.
The actual figure ranged from a high of 96% in 2008 to a low of 92% in 2010, and did not change significantly over the five years under consideration, despite UK graduate numbers increasing by around a quarter during the same period (from 650 in 2007, to 819 in 2012). Meanwhile, the College has registered an average of 618 overseas graduates annually during this time.
The survey did show that it was taking graduates slightly longer to secure their posts, with a shift from 85% securing work under three months in 2008, to 71% in 2012.
The results seem to suggest some small differences in the time taken for men and women to find their first jobs, with men finding jobs slightly quicker, although the vast majority of both genders found veterinary work.
Jacqui Molyneux, RCVS President said: "After the announcement from the University of Surrey that it will be opening a new vet school in the near future, there was a great deal of discussion amongst the profession about how easily new graduates could find employment. I undertook to get some real facts and am pleased to find that the picture is not as gloomy as predicted.
However, Jacqui said she was concerned that there has been a slight increase in the proportion of respondents who left their first position after a relatively short period of time. Amongst 2012 graduates, over 40% of those who had left their first position did so within three months of starting work. However it must be stressed that only 18% of those answering the survey who graduated in 2012 had already left their first position. Jacqui said: "Although the turn-over in first jobs seems to be, in part, due to an increase in temporary posts, I am saddened to see that the most commonly-cited reason for graduates leaving their first job was lack of support from their employers or professional colleagues.
"This is an area that we, as a profession, must address. As I have told all the students I have admitted to the College, their first jobs will influence their whole careers, and getting adequate support is probably the single most important factor. Meanwhile, it is heartening to see that nearly all of those moving on have obtained further employment."
Although the survey was sent to all those UK graduates who had registered with the RCVS within the last five years, the contact details for those who had subsequently de-registered may not have been up to date, which may mean that those who had de-registered because they could not find work were not well represented. However, the College says it thinks it is more likely that these individuals would have switched to the 'non-practising' category.
A summary of the headline survey results will be available at www.rcvs.org.uk/publications. The full findings, which also looked at the time taken to complete the Professional Development Phase and the type and location of work sought, will be available in due course.
The RCVS Charitable Trust, has announced a complete rebranding that includes a change of name - RCVS Knowledge - and the refocus of its mission on supporting the flourishing evidence based veterinary medicine (EBVM) movement across the globe.
For the past 50 years, the charity has been known as a small funder of veterinary research and the home of the only freely-accessible library for the practising veterinary community in the UK.
Nick Royle, Executive Director of RCVS Knowledge said: "RCVS Knowledge is a name that encompasses our three core offerings: historical knowledge represented by our valuable Historical Collection, present knowledge, represented by our library, and future knowledge, represented by the new evidence based veterinary medicine project, which is underpinned by our grants programme."
The RCVS Knowledge re-launch goes further than a mere name change, and comes as the charity refocuses its efforts to become a global intermediary for EBVM, a direction reached following a period of consultation, and on the back of a successful symposium on the subject held at the end of 2012.
Nick, a former CEO of the human evidence based medicine resource, The Cochrane Collaboration, said: "Today, veterinary surgeons and nurses are required to take account of an ever-increasing pool of scientific data, the owners' values and preferences, and their own clinical expertise when making clinical decisions. RCVS Knowledge is ideally placed to generate, collate and distribute this information to support evidence based practices. We aim to develop tools to assist practitioners to quickly make well-informed treatment decisions."
As part of the new direction, the Historical Collection will be made accessible and available online, following a start-up grant from the Wellcome Trust. Clare Boulton, Head of Library and Information Services, said: "The Collection contains priceless and fascinating material, covering topics such as early horse-care and management, veterinary expeditions of discovery through Africa, and research that made the British Cavalry horses of 1914 the finest in the world. But this is just the beginning. If you have relevant experience or some funds that could help us, please get in touch."
Meanwhile, RCVS Knowledge's Library and Information Service will be re-designed to make it much more than shelves of journals, but rather a resource with the capacity to steer first-rate care and innovation, and an information engine capable of driving evidence based veterinary medicine at a global level.
The Grants and Awards program, for which the former RCVS Charitable Trust has been known, will be redesigned to celebrate professional excellence, and to address gaps in veterinary knowledge. Nick said: "We are aware of the responsibilities that veterinary surgeons and nurses face every day and feel we are in a position to support their decision making. We would like to urge every veterinary professional with an interest in EBVM, a curiosity about the history of their profession or a need to access up-to-date research to get in touch, so that we can keep you up to date with developments."
Maggie Fisher MRCVS, the parasitologist and chairman of ESCCAP (European Scientific Counsel Companion Animal Parasites), has highlighted studies which demonstrate an association between the common parasite, Toxocara spp. and human disease, and has called on the profession to help reduce the damaging and widespread effects of this parasite.
Maggie says that many in the profession may not be aware that Toxocara eggs aren't actually infective when they are first passed in an animal's stools, sometimes taking weeks to develop to this stage. Eggs persist long after pet waste has naturally washed away too, so the risk of infection still exists even in environments that appear to be clean and safe. Interestingly, there seems to be only a very loose (and according to some studies, entirely absent) link between owning a pet and an increased risk of human Toxocara infection, suggesting that most infections are acquired from the environment1,2 . Education of pet owners about responsible pet ownership, including appropriate worming and picking up their dog's waste quickly is essential to reduce this environmental infection risk.
The parasite's larval stages cause disease in humans as they migrate through body tissues, with retinal damage a previously well identified consequence. However, Maggie has identified studies which suggest a whole range of common conditions that may also be attributable to Toxocara infection. One study3 included 425 children displaying signs of a persistent cough and 1600 asymptomatic children as controls. Blood tests confirmed that a statistically significant 32% of the symptomatic group were positive for Toxocara antibodies, compared to just 17% of the asymptomatic control group. What's more, when given a week's course of an appropriate anthelmintic, the vast majority of symptomatic children had a greatly reduced and frequently absent requirement for inhaled corticosteroids to control their symptoms when re-examined by the study team a year later.
Numerous other studies from around the world have shown similar strong associations with asthma, allergies and epilepsy. One nationally representative US study even showed an alarming association with Toxocara infection and reduced cognitive function in children2 . Those that were positive for antibodies to the parasite on blood tests (proving prior exposure) scored significantly lower on tests assessing verbal and manual dexterity as well as maths and reading abilities2 .
So, what should veterinary staff and SQPs be telling clients? Maggie says you should be advising pet owners to worm pets regularly (at least four times a year) with an effective anthelmintic from an appropriately young age (2 weeks of age for puppies and 3 weeks of age for kittens, because transfer of the parasite to puppies before birth and to kittens via milk is a feature of the parasite lifecycle). Reducing pets' access to raw food and hunting activities can also help. This is in addition to more general recommendations including cooking food well and making sure children wash their hands before eating.
Maggie said: "Vets, nurses and SQPs are perfectly placed to make sure that pet owners are aware of the risks and take precautions to protect themselves and the wider general public."
For further information about effective control of Toxocara and a wide range of other companion animal parasites, visit www.esccapuk.org.uk. To view all the presentations from the 'Everyday Parasites' CPD day, visit www.esccapuk-cpd.co.uk.
References:
Vets Now has published a response to the RCVS DC ruling in which Munhuwepasi Chikosi, a locum working for the company, was struck off for delaying an emergency OOH home visit.
The response is available in full here: http://www.vets-now.com/news/?item=4191
BCF Technology has launched the Cuattro Small Animal DR, a digital radiography system which it describes as 'revolutionary for the small animal veterinary practice'.
BCF says the system transforms small animal practices' imaging function, producing diagnostic X-ray images in 5 seconds.
Craig Hoines from BCF said: "The Cuattro Small Animal DR is a smart investment for any practice looking to grow and expand. Investing in your imaging function is a perfect way to do this. The Small Animal DR will allow you to cut X-ray study time significantly, improve in-practice workflows and speed up patient care without increasing costs. The team at BCF can show you how."
According to the company. the Small Animal DR can be practical investment for any size of small animal practice.
For more information, visit www.bcftechnology.com or call +44(0)1506 460 023 to arrange a demonstration.
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against an Essex-based veterinary surgeon who qualified in 1969, following his undertakings firstly to request removal from the RCVS Register and secondly never apply to be restored to it.
At the hearing, which had originally been listed for seven days, Geoffrey Raymond Oliver, 68, was charged with serious professional misconduct over allegations of his inadequate treatment of two dogs and a cat (belonging to three different clients) between 2010 and 2012; inadequate record keeping; failures to deal honestly or properly with his clients; and, failure to heed advice from the RCVS Preliminary Investigation Committee about the importance of proper communication between veterinary surgeons and their clients.
However, before the Committee heard evidence on any aspect of these charges, Mr Oliver lodged his application for adjournment. The Committee therefore made no findings on the charges, and emphasised they had neither been proved against, nor admitted by, him.
The Committee noted that there had been no adverse findings against Mr Oliver during his professional career, that his practice was now closed and that he had no intention of returning to practise in the future. Should he subsequently apply to be restored to the Register, the Committee would resume its consideration of the charges, along with his breach of the undertaking.
The Committee was advised that none of the complainants in the case - which could have incurred considerable time and costs - dissented from the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "The Committee has concluded that no useful purpose would be served were it to insist on a full hearing [and it] would be a disproportionate waste of...resources [to do so]. The Committee is satisfied that [granting the adjournment application] protects the welfare of animals and...is in the public interest."
The Committee then accepted Mr Oliver's undertakings, including the removal of his name from the Register with immediate effect.
Professor Lees added: "So that he is in no doubt about the matter, the Committee reminds [Mr Oliver] that, when referring clients of his former practice elsewhere, he should be careful to avoid giving them any advice about the diagnosis or treatment of their animals."
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The RCVS is now accepting disclosures from veterinary surgeons about any criminal cautions, convictions or adverse findings they may have against them, as part of a voluntary period before the requirement to disclose commences in 2014.
The requirement that veterinary surgeons notify the College about criminal cautions, convictions or adverse findings on registration, and on an annual basis as part of their registration renewal each March, was introduced as part of the Code of Professional Conduct in 2012 (section 5.3, see Notes to Editors). However, the College has allowed a bedding-in period for the Code before enforcing the requirement.
From 2014, new registrants will have to disclose any criminal cautions, convictions or adverse findings that may affect registration (for example, those from university fitness to practise procedures).
Veterinary surgeons already on the Register (including overseas and non-practising categories, as well as UK-practising) will only be required to disclose criminal cautions, convictions or adverse findings that have occurred since April 2006. Fixed-penalty motoring offences are excluded.
The veterinary profession has fallen under the Notifiable Occupations Scheme since April 2006, which means that serious convictions are already passed to the College from the police.
If a veterinary surgeon declares a criminal conviction, this will be initially considered by the Registrar, and, if necessary, referred to the Preliminary Investigation Committee. In some cases, the matter will be referred on to the Disciplinary Committee to decide if the nature of the caution or conviction affects the veterinary surgeon's fitness to practise - in which case the usual sanctions of removal or suspension from the Register could apply.
Eleanor Ferguson, Head of Professional Conduct said: "We hope, through this new requirement, to increase the public's confidence in the veterinary profession, and to safeguard animal health and welfare. The move brings the veterinary profession into line with many others - including registered veterinary nurses, who have made such a disclosure since their Register was introduced, in 2007."
The RCVS has launched a dedicated advice line to assist affected veterinary surgeons, on 07818 113 056, open Monday to Friday, 11am-4pm.
Callers will speak to one of three RCVS solicitors who can advise on the process and the possible outcomes of disclosure. Alternatively, veterinary surgeons can contact disclosure@rcvs.org.uk.
Detailed information regarding the requirement, including examples of the kinds of convictions that may be referred to the Preliminary Investigation Committee, and a disclosure form, can be found on www.rcvs.org.uk/convictions.
Dechra Veterinary Products has launched Vitamin K1 tablets for dogs, which help reverse the effects of exposure to anticoagulant rodenticides.
The launch of the NFA-VPS licensed 50mg tablets means that veterinary professionals can have a ready supply of Vitamin K when treating animals which have been exposed or may have been exposed to serious poisoning. Previously, the tablets where only available as a special import certificate product following Dechra's acquisition of Eurovet.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Vitamin K1 is an absolutely key therapy in the treatment of potential and accidental exposures to anticoagulant poisoning in animals, mainly in pet dogs. It helps to assist with blood clotting, and the treatment protocol advises continued oral therapy following an initial injectable preparation of Vitamin K.
"The Veterinary Poisons Information Service has received more than 6,000 calls so far this year to its helpline regarding suspected or confirmed poisoning of all types of animals, whether accidental or deliberate exposure.
"We had been able to offer the Vitamin K1 injection and tablets via a SIC, when previously sometimes only preparations for human use were available. Therefore, we are delighted to now launch a licensed tablet which will ensure a ready supply and speed of therapy for animals affected by anticoagulant rodenticides."
Carol added: "Anticoagulant poisoning queries are already the second most common type received by the Veterinary Poisons Information Service, and with the launch of these tablets, veterinary professions will be able to have a ready supply of vitamin K to hand. We would recommend that all practices consider stocking this product."
Vitamin K1 50mg tablets, for the treatment of anticoagulant poisoning following parenteral treatment, are available in boxes of 14 tablets, in blister packs of seven tablets.
For more information, please visit www.dechra.co.uk
Improve International has launched a new course for veterinary receptionists to achieve the nationally accredited Edexcel QCF Level 2 Certificate in Customer Service, but with the assessment tailored specifically to demonstrate excellence in veterinary client care.
Veterinary receptionists may be able to benefit from government funding to enable them to study for the qualification, which Improve says can be delivered either at its HQ in Swindon or in practice.
Government funding is available for students of the Certificate in Customer Service without an existing Level 2 qualification in another subject. Requests also depend on the age of the learner and will be assessed on an individual basis by Improve's local Edexcel accredited centre in Swindon.
The 30 hour course features three core units, assessed by a one hour online test:
David Babington MRCVS, founder of Improve International said: "A successful veterinary practice is no longer just about a 'good' vet or nurse. It's about a practice team pulling together and playing their role to the top of their ability. The key role played by receptionists in terms of creating that vital first impression and helping to maintain client loyalty cannot be understated and we wanted to offer them a form of training that would help them develop their skills while achieving a nationally recognised qualification. We look forward to welcoming our first students later this year."
For further information or to register, email enquiries@improve-international.com; visit www.improvecpd.com or call 01793 759159.
Virbac has launched Marfloquin, a marbofloxacin-based antibiotic indicated for the treatment of multiple infectious diseases in cats and dogs.
Marfloquin is presented as a palatable, divisible tablet for once daily administration and is available in three tablet strengths:
Virbac Companion Animal Marketing Manager Simon Boulton MRCVS said: "Marbofloxacin is valued by practices for its efficacy in treating a wide range of skin, soft tissue, urinary tract and respiratory tract infections. The launch of Marfloquin gives them a cost-effective alternative and strengthens our existing antibiotic range, which includes Rilexine (cefalexin) and Enrox (enrofloxacin)."
For more information, contact your territory manager or call Virbac on 01359 243243
IDEXX Laboratories has unveiled the Angio Detect Test, a world-first diagnostic test which allows veterinary surgeons to detect the lungworm Angiostrongylus vasorum in clinic, with almost immediate results.
Until now, vets have had to rely on the Baermann method to detect A. vasorum, which can present with varied and confusing clinical symptoms. However, the Baermann test has had limited use because it requires faecal samples from the same dog to be collected on three successive days, and the results can be compromised by the intermittent shedding of larvae. IDEXX says this leads many experts to believe that A. vasorum is widely under-diagnosed.
The Angio Detect Test works by detecting an A. vasorum specific antigen in the animal's blood. The test can be used in-clinic using a serum or plasma sample and returns results within 15 minutes. Depending on results, you can offer a licensed treatment or talk about a preventative treatment regime and refer the client to a source of further information, such as lungworm.co.uk.
IDEXX suggests that because the test is inexpensive, it can be used for the diagnosis of A. vasorum suspect dogs and in those with non-specific signs. Indeed, in market research1, 94% of veterinary surgeons said they would use the test in dogs presenting with A. vasorum signs.
In endemic areas, it can be considered as an additional pre-surgical measure to avoid complications associated with coagulopathy.
This test comes at a time when concern about A. vasorum has been growing. A survey of 150 veterinary practices across the UK in January 2013 recorded a total of 952 suspected cases (157 laboratory confirmed), with 81 deaths thought to have been caused by the parasite2. The Angio Detect Test should help to improve the picture, as confirmed cases are logged onto incidence maps so vets can check prevalence in their area.
Ian Wright from the European Scientific Counsel Companion Animal Parasites (ESCCAP) said: "In recent years, there has been spread of the A. vasorum parasite across the UK with cases now being reported as far north as Scotland. It was initially thought this may be due to increased reporting rather than genuine spread, but this pattern in the UK has been mirrored in many other countries and would appear to represent a true emergence of disease. Although the cause of this spread is not known for certain, increasing slug and snail numbers combined with increased pet movement and urbanisation of foxes are all likely to have played a significant part. These factors make A. vasorum a year round rather than seasonal threat.
"Any new diagnostic test that can quickly confirm a case of lungworm is a fantastic development and will help save dogs' lives and give us even greater insight into the extent of the spread of the parasite."
Graham Bilbrough, veterinary surgeon and European medical affairs manager for IDEXX Laboratories, said: "Up until now, testing methods have been time consuming to the client and costly, so the launch of the Angio Detect Test, together with recognition of clinical signs and early treatment will really help to prevent A. vasorum related fatalities in dogs. We also know that some dogs have subclinical angiostrongylosis, and this new test will help uncover this hidden problem before the surgical blade makes a cut. Difficulties in diagnosis have also meant that the full prevalence of A. vasorum in the UK has been relatively unknown. This test will allow veterinary surgeons to quickly identify the parasite and treat it if found. They shouldn't forget that other dogs in the household and the area are also at particular risk from the parasite."
The Angio Detect Test is available now in the UK, and will be launched in other European countries later this year. For more information on the test, visit www.idexx.co.uk/angio or speak to your IDEXX sales representative. For further information and free CPD on A. vasorum and other parasites, visit www.jungleforvets.co.uk or speak to your Bayer territory manager.
Petplan has been awarded an Insurance Times Tech Award for its social media campaign entitled "Like & Donate", which was devised to support two animal charities, the Dogs Trust and Cats Protection.
As part of the campaign, pet lovers are being encouraged to donate a food pouch to either charity by "liking" the Petplan Facebook page; with one "like" equalling one pouch of food for either the cat or dog charity.
The Facebook app also allows Petplan's Facebook fans to track the progress of donations and encourage friends to visit the page and support their chosen charity. The initiative has resulted in over 48,000 food pouches being donated to the charities with the Cats Protection receiving over 29,000 "likes" and the Dogs Trust gaining 19,500.
Petplan's Head of Marketing, Isabella von Mesterhazy said: "We are delighted our Like & Donate campaign has been awarded Best Use of Social Media. At Petplan we work with over 1,700 animal charities and our Like & Donate campaign has further helped to support the fantastic work of both the Dogs Trust and Cats Protection in rehoming dogs and cats across the UK."
To take part in Petplan's "Like & Donate" programme visit www.Facebook.co.uk/Petplan.
Virbac, in conjunction with the European Veterinary Dental Society, has launched an online dental charting system called the Electronic Veterinary Dental Scoring System for use by small animal practitioners.
The system aims to enhance the performance of clinicians conducting dentistry and to encourage a thorough review of the oral cavity during the annual check up.
The system allows you to record clinical findings on online dental charts and build up a history for each patient. There are also a series of tutorials to help in making clinical decisions. Virbac says the e-VDS system also encourages owner compliance with treatment regimes as it provides downloadable materials, including an assessment of their pet and follow up reports.
Dr Gottfried Morgenegg-Wegmüller, who was the EVDS project lead on this development, said: "It was always my vision to give veterinary dentistry the importance it deserves. The most effective way to achieve this is by targeting the general practitioner and encouraging them to have a closer look at the oral cavity of their patients."
Victoria Hudson, Product Manager for dental products at Virbac, said: "Poor dental health is a major issue for dogs and cats yet many practices are yet to capitalise on the opportunity to help increase the animal's welfare and health. Many owners are simply unaware of the importance of caring for their pet's teeth.
"The new e-VDS system is a great leap forward in dental care, offering not just electronic charting but a raft of additional support materials, all of which are practical and easy to use. We hope many practices will be keen to try it - and will soon be reaping the benefit!"
e-VDS is available free of charge on http://www.my-virbac.co.uk/, Virbac's practice support portal. Practices can also contact their territory manager for more details.
The RCVS has launched a mobile version of the Code of Professional Conduct for veterinary surgeons and veterinary nurses: an app for Android devices and a web app for Apple users.
Once installed, the app provides smartphone and tablet users with a mobile-friendly version of the Code and all 27 chapters of supporting guidance in their pockets, even when there is no network connection. Whenever the Code is updated, the latest version will be available to download the next time the device is online.
Head of Communications, Lizzie Lockett, said: "Our new app provides easy access to the Code, so busy veterinary surgeons and veterinary nurses can now keep our guidance to hand, even when out and about. It's never been easier to ensure that you're always working to the Code's principles of veterinary practice and professional responsibilities."
The app also offers a keyword search of the whole Code and supporting guidance, links to other sources of information and contact details for further advice over the phone or email.
To install the RCVS Code of Professional Conduct app on your android device, visit Google Play and search for 'RCVS code'. To install it on an Apple device, visit the RCVS Code web pages in the device's internet browser, click on the app link in the Code tool box on the right hand side, and follow the instructions.
Alternatively, a copy of the full Code and all supporting guidance can now be downloaded in PDF format from the RCVS website, date-stamped so that you know when it was last amended.
Visit www.rcvs.org.uk/code or www.rcvs.org.uk/vncode and see the 'Code tools' box for both the PDF and the web app.
The College says it would very much like feedback about the app, or suggestions for future apps - email Christine James in the Communications Department, on christinej@rcvs.org.uk.
Agria Pet Insurance has announced a competition for two veterinary nurses to win tickets and hotel accommodation for the BVNA Congress '00-heaven' Party Night.
BVNA Congress is taking place at the Telford International Centre in Shropshire from 11th-13th October, with Party Night happening on Saturday 12th.
To enter the competition, you need to complete a 2-minute online poll about how your practice uses pet insurance. Click here
The competition closes on 6th October 2013.
Bimeda has announced the launch of Butagran Equi (phenylbutazone), to join its range of analgesics and anti-inflammatories.
Bimeda says that Butagran Equi provides rapid onset of activity with the added convenience for horse owners or professionals of being presented as an easy-to-administer sweetened powder.
Indications include musculo-skeletal conditions that require relief from pain and a reduction in the associated inflammation, including lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Head of Bimeda technical services Padraig Hyland MVB said: "Butagran Equi is particularly suited where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation and can be used as an anti-pyretic where this is considered advisable, such as in viral respiratory infections. And being a sweetened powder it's quite straightforward for horse owners to administer and dose as prescribed."
He added: "Butagran Equi follows the launch of a number of new products and is proof our desire to provide a comprehensive and relevant equine portfolio backed up with first class technical support."
Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland.
Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination of glucosamine hydrochloride, chondroitin sulphate, avocado/soybean unsaponifiables (ASU), and tea polyphenols. Novartis says these compounds work synergistically to protect the cartilage, thereby playing an important role in supporting and maintaining joint health.
Novartis highlights a 2007 study which, according to the company, demonstrates that the combination of ASU, chondroitin sulphate, and glucosamine hydrochloride delivers incremental benefits compared to the combination of chondroitin sulphate and glucosamine hydrochloride alone.1
Dasuquin is available in flavoured chewable tablets in 80-count containers. Dasuquin is available in two strengths: small-to-medium dogs weighing between 5 and 25 kg and for large dogs weighing over 25 to 50 kg.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "This is a fitting addition to our overall orthopaedic health offering for vets and pet owners. Dasuquin brings vets and dog owners advanced joint health support with the next generation of the popular Cosequin family."
Dasuquin is available from Novartis Animal Health in the United Kingdom and Ireland from licensed veterinary wholesalers. For more information on Dasuquin, contact your Novartis Animal Health Territory Manager
Reference: